Summary:
Ulcerative Colitis Study at Carolina’s GI Research
ULCERATIVE COLITIS doesn’t have to determine the memories you make.
Our team of medical professionals is evaluating an oral investigational drug called filgotinib to see if it reduces the signs and symptoms of UC by lowering the immune response that causes inflammation in the digestive system.
Qualified Participants Must:
• If you are living with ulcerative colitis, our clinical research study may be for you
Qualified Participants May Receive:
Qualified participants may:
- Try an oral investigational drug to see if it reduces the signs and symptoms of UC
- Receive study drug and monitoring from a local study doctor at no cost
- Be eligible to participate in a long-term extension study
- Receive reimbursement for study-related travel expenses